Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Diaz-Buxo
J A
JA
Fresenius Medical Care North America, Lexington, Maryland, USA. jose.diaz-buxo@fmc-na.com
Crawford
T L
TL
Bailie
G R
GR
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002437:Cefazolin / Q000008:administration & dosage / Q000493:pharmacokinetics; D002511:Cephalosporins / Q000008:administration & dosage / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D010406:Penicillins / Q000008:administration & dosage / Q000493:pharmacokinetics; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D010878:Piperacillin / Q000008:administration & dosage / Q000493:pharmacokinetics; D014031:Tobramycin / Q000008:administration & dosage / Q000493:pharmacokinetics
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D002437:Cefazolin; D014031:Tobramycin; D010878:Piperacillin